|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Tracon Pharmaceuticals, Inc. (TCON) |
|
|
$0.26 0.00 (0.00%) as of 4:30 Fri 4/5
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
13,680,000 |
Market
Cap: |
3.49(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.1322 - $0.789 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile TRACON Pharmaceuticals is a biopharmaceutical company. Co. has a collaboration and clinical trial agreement for the development of envafolimab, an investigational PD-L1 single-domain antibody for the treatment of soft tissue sarcoma in North America. Other clinical stage oncology product candidates include: YH001, which is a monospecific investigational CTLA-4 antibody, that Co. licensed from Eucure (Beijing) Biopharma Co., Ltd. and Biocytogen Pharmaceuticals (Beijing) Co., Ltd., TRC102, which is a small molecule for the treatment of mesothelioma, lung cancer, glioblastoma and solid tumors, and TJ004309, which is a CD73 antibody for the treatment of solid tumors.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,446,193 |
Total Buy Value |
$0 |
$0 |
$0 |
$1,942,949 |
Total People Bought |
0 |
0 |
0 |
3 |
Total Buy Transactions |
0 |
0 |
0 |
34 |
Total Shares Sold |
0 |
4,764,008 |
4,764,008 |
4,765,667 |
Total Sell Value |
$0 |
$1,401,571 |
$1,401,571 |
$1,403,938 |
Total People Sold |
0 |
1 |
1 |
2 |
Total Sell Transactions |
0 |
1 |
1 |
3 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Opaleye Management Inc. |
10% Owner |
|
2023-11-10 |
4 |
S |
$0.29 |
$1,401,571 |
I/I |
(4,764,008) |
0 |
|
-98% |
|
Theuer Charles |
PRESIDENT AND CEO |
|
2023-10-20 |
4 |
A |
$0.13 |
$467 |
D/D |
3,500 |
406,417 |
|
- |
|
Theuer Charles |
President and CEO |
|
2023-04-27 |
4 |
B |
$0.75 |
$35,250 |
D/D |
47,000 |
399,417 |
2.81 |
-66% |
|
Theuer Charles |
President and CEO |
|
2023-04-26 |
4 |
B |
$0.66 |
$2,639 |
D/D |
3,999 |
352,417 |
2.73 |
-68% |
|
Brown Scott B. |
CHIEF FINANCIAL OFFICER |
|
2023-04-20 |
4 |
A |
$0.14 |
$482 |
D/D |
3,500 |
25,128 |
|
- |
|
Theuer Charles |
PRESIDENT AND CEO |
|
2023-04-20 |
4 |
A |
$0.14 |
$482 |
D/D |
3,500 |
402,917 |
|
- |
|
Opaleye Management Inc. |
10% Owner |
|
2023-03-09 |
4 |
B |
$1.38 |
$240,821 |
I/I |
174,508 |
4,324,508 |
1.5 |
-78% |
|
Theuer Charles |
President and CEO |
|
2023-03-01 |
4 |
B |
$1.52 |
$7,296 |
D/D |
4,800 |
344,918 |
2.81 |
-80% |
|
Theuer Charles |
President and CEO |
|
2023-02-28 |
4 |
B |
$1.52 |
$304 |
D/D |
200 |
340,118 |
2.73 |
-81% |
|
Adams Bonne J. |
Chief Operating OfficerOfficer |
|
2023-02-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,267 |
|
-68% |
|
Theuer Charles |
President and CEO |
|
2023-01-18 |
4 |
B |
$1.62 |
$11,016 |
D/D |
6,800 |
339,918 |
2.81 |
-64% |
|
Brown Scott B. |
Chief Financial Officer |
|
2022-12-29 |
4 |
B |
$1.49 |
$5,215 |
D/D |
3,500 |
21,628 |
2.74 |
-53% |
|
Larue William R |
Director |
|
2022-12-21 |
4 |
S |
$1.26 |
$151 |
D/D |
(120) |
7,763 |
|
43% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-12-14 |
4 |
B |
$1.24 |
$209,877 |
I/I |
167,500 |
440,000 |
1.5 |
-39% |
|
Theuer Charles |
President and CEO |
|
2022-12-14 |
4 |
B |
$1.29 |
$29,755 |
D/D |
23,000 |
333,118 |
2.81 |
-39% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-12-06 |
4 |
S |
$1.44 |
$2,216 |
I/I |
(1,539) |
4,010,000 |
|
-26% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-12-06 |
4 |
OE |
$0.01 |
$2,215 |
I/I |
221,539 |
4,011,539 |
|
- |
|
Theuer Charles |
President and CEO |
|
2022-11-18 |
4 |
B |
$1.41 |
$19,599 |
D/D |
13,900 |
310,118 |
2.81 |
39% |
|
Theuer Charles |
President and CEO |
|
2022-11-03 |
4 |
B |
$1.52 |
$13,984 |
D/D |
9,200 |
296,218 |
2.81 |
3% |
|
Theuer Charles |
President and CEO |
|
2022-11-02 |
4 |
B |
$1.59 |
$9,540 |
D/D |
6,000 |
287,018 |
2.81 |
-4% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-10-18 |
4 |
B |
$1.65 |
$20,625 |
I/I |
12,500 |
4,125,000 |
1.5 |
-9% |
|
Theuer Charles |
President and CEO |
|
2022-10-07 |
4 |
B |
$1.77 |
$8,850 |
D/D |
5,000 |
277,518 |
2.81 |
-4% |
|
Theuer Charles |
President and CEO |
|
2022-10-03 |
4 |
B |
$1.67 |
$8,350 |
D/D |
5,000 |
272,518 |
2.81 |
-3% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-09-29 |
4 |
B |
$1.74 |
$16,370 |
I/I |
9,400 |
410,000 |
1.5 |
-4% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-09-27 |
4 |
B |
$1.69 |
$2,877 |
I/I |
1,700 |
400,600 |
1.42 |
- |
|
241 Records found
|
|
Page 1 of 10 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|